Amlexanox

FDA Approved: * September 29, 2004
Pharm Company: * ULURU
Category: Ulcer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Amlexanox Overview

Amlexanox (trade name Aphthasol) is an anti-inflammatory antiallergic immunomodulator used to treat recurrent aphthous ulcers (canker sores), and (in Japan) several inflammatory conditions. This drug has been discontinued in the U.S.[1] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Mechanism of action 5 Chemistry 6 Pharmacokinetics 7 History 8 Society and culture 8.1 Legal status 8.2 Economics 9 Research 10 Synthesis 11 References Medical uses Aml...

Read more Amlexanox Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Amlexanox

Recent Amlexanox Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Amlexanox
  • Film: 2mg
  • Paste: 5%
  • Patch: 2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Amlexanox or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA